Skip to main content
Capricor Therapeutics, Inc. (FRA:4LN2)
Germany flag Germany · Delayed Price · Currency is EUR
22.05
-2.60 (-10.55%)
At close: Dec 4, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2011 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
Transformative Cell and Exosome-based Therapeutics
22.27M
Log In
Log In
Log In
Log In
Upgrade
Transformative Cell and Exosome-based Therapeutics Growth
-11.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2011 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
United States
22.27M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-11.55%
Log In
Log In
Log In
Log In
Upgrade